Proteomic Analysis of Synovial Fluids in Joint Degeneration

Proteomic analysis of synovial fluid has emerged as a powerful approach to decipher the molecular underpinnings of joint degeneration. Synovial fluid bathes articular surfaces and reflects the local biochemical milieu of cartilage, synovium and subchondral bone. By applying advanced mass spectrometry and fractionation strategies, researchers have catalogued hundreds of proteins, including glycoproteins, cytokines and extracellular matrix fragments. Comparative profiling between healthy joints and those afflicted by osteoarthritis or rheumatoid arthritis has revealed disease-specific signatures, highlighted dysregulated pathways of cartilage breakdown and inflammation, and identified neopeptides deriving from matrix proteolysis. Such discoveries underpin efforts to develop early diagnostic biomarkers, stratify patients for targeted therapies and monitor therapeutic response. Advances in sample preparation, peptide‐based depletion of high‐abundance proteins and label-free quantification have enhanced depth of coverage and reproducibility. As the field moves towards integration with metabolomic and transcriptomic data, proteomic insights are informing mechanistic models of joint homeostasis, unravelling novel therapeutic targets and paving the way for personalised management of joint degeneration on a global scale.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Proteomic Analysis of Synovial Fluids in Joint Degeneration publication trend

The graph below shows the total number of articles in proteomic analysis of synovial fluids in joint degeneration across all publications each year (not limited to Nature Index journals).

Technical terms

Proteomics: The large-scale study of the full complement of proteins in a biological sample, including their identities, quantities and modifications.

Synovial fluid: The lubricating liquid found within joint cavities, providing nutrients to cartilage and reflecting the joint’s biochemical environment.

Mass spectrometry: An analytical technique that ionises chemical species and sorts the ions based on their mass-to-charge ratio, enabling protein identification and quantification.

Biomarker: A measurable molecule or molecular signature that indicates a biological state or condition, such as early joint degeneration or response to therapy.

Neopeptide: A peptide fragment generated by specific proteolytic cleavage of matrix proteins, often serving as an indicator of tissue remodelling or degradation.

References

1. Proteomic analysis of human osteoarthritis synovial fluid. Clinical Proteomics (2014).
2. Comprehensive protein profiling of synovial fluid in osteoarthritis following protein equalization. Osteoarthritis and Cartilage (2015).
3. Identification of tissue-dependent proteins in knee OA synovial fluid. Osteoarthritis and Cartilage (2020).